[Preprint] Estudo randomizado | Fluvoxamina reduz o risco de hospitalização em pacientes com Covid-19.
24 Ago, 2021 | 11:54hConteúdos relacionados:
Comentário no Twitter
@TogetherTrial Manuscript Pre-print regarding #Fluvoxamine for early #COVID19 is online athttps://t.co/teHqMlowld
demonstrating ~30% relative reduction in ER visits / hospitalizations with fluvoxamine 100mg 2x/day in a 10-site, double-blind randomized trial. #IDtwitter pic.twitter.com/727by0lqft— David Boulware, MD MPH (@boulware_dr) August 23, 2021